The Vita Coco Company: Growth Outlook Remains Healthy (NASDAQ:COCO)
· seekingalpha.com
Reiterate a buy on Vita Coco (COCO): Q2 sales +28%, margin to 48.7%, and Copra boost growth.
I'm a passionate investor with a strong foundation in fundamental analysis and a keen eye for identifying undervalued companies with long-term growth potential....